BIOMAT Database Logo BIOMAT Database Logo

Mutations in the v-mos gene abolish its ability to induce differentiation but not transformation. 1995

N Kurata, and H Akiyama, and H Hosoya, and H Aoki, and K Ishikawa, and T Marunouchi
Division of Cell Biology, Fujita Health University, Aichi/Japan.

The v-mos oncogene product has the ability to induce differentiation in human monocytic leukemia U937 cells, thereby arresting cell proliferation, and also exhibits transforming activity in mouse NIH3T3 cells. Mutation in the v-mos gene consisting of one or two amino acid substitutions in the putative ATP-binding domain impaired its differentiation-inducing activity although mutant proteins showed rather higher levels of autophosphorylation in vitro. Macrophage-specific characteristics such as their morphology, expression of C3b receptor and Fc receptor, and production of interleukin-1 beta and tumor necrosis factor alpha, were equally diminished in cells transfected with mutant mos genes when compared to those with intact v-mos. The ability of the gene to arrest the proliferation of U937 cells was likewise diminished, while the transforming efficiency of the intact and mutant mos genes were essentially the same. These results suggest that the mos product functions differently in cell differentiation and transformation.

UI MeSH Term Description Entries
D007948 Leukemia, Monocytic, Acute An acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage including monoblasts, promonocytes, and MONOCYTES. Leukemia, Monoblastic, Acute,Leukemia, Myeloid, Acute, M5,Leukemia, Myeloid, Schilling-Type,Monoblastic Leukemia, Acute,Monocytic Leukemia, Acute,Myeloid Leukemia, Acute, M5,Myeloid Leukemia, Schilling-Type,Leukemia, Acute Monocytic,Leukemia, Myeloid, Schilling Type,Acute Monoblastic Leukemia,Acute Monoblastic Leukemias,Acute Monocytic Leukemia,Acute Monocytic Leukemias,Leukemia, Schilling-Type Myeloid,Leukemias, Acute Monoblastic,Leukemias, Acute Monocytic,Monoblastic Leukemias, Acute,Monocytic Leukemias, Acute,Myeloid Leukemia, Schilling Type,Schilling-Type Myeloid Leukemia
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D014170 Transformation, Genetic Change brought about to an organisms genetic composition by unidirectional transfer (TRANSFECTION; TRANSDUCTION, GENETIC; CONJUGATION, GENETIC, etc.) and incorporation of foreign DNA into prokaryotic or eukaryotic cells by recombination of part or all of that DNA into the cell's genome. Genetic Transformation,Genetic Transformations,Transformations, Genetic
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

N Kurata, and H Akiyama, and H Hosoya, and H Aoki, and K Ishikawa, and T Marunouchi
Point mutations in BHV-1 Us3 gene abolish its ability to induce cytoskeletal changes in various cell types.
June 2010, Veterinary microbiology,
N Kurata, and H Akiyama, and H Hosoya, and H Aoki, and K Ishikawa, and T Marunouchi
Sodium bisulfite induces morphological transformation of cultured Syrian hamster embryo cells but lacks the ability to induce detectable gene mutations, chromosome mutations or DNA damage.
October 1990, Carcinogenesis,
N Kurata, and H Akiyama, and H Hosoya, and H Aoki, and K Ishikawa, and T Marunouchi
Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance.
December 1989, Molecular and cellular biology,
N Kurata, and H Akiyama, and H Hosoya, and H Aoki, and K Ishikawa, and T Marunouchi
Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
January 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research,
N Kurata, and H Akiyama, and H Hosoya, and H Aoki, and K Ishikawa, and T Marunouchi
Mutations in SPK1/RAD53 that specifically abolish checkpoint but not growth-related functions.
February 1997, Current genetics,
N Kurata, and H Akiyama, and H Hosoya, and H Aoki, and K Ishikawa, and T Marunouchi
Mutations within the 5' half of the avian retrovirus MC29 v-myc gene alter or abolish transformation of chicken embryo fibroblasts and macrophages.
May 1992, Journal of virology,
N Kurata, and H Akiyama, and H Hosoya, and H Aoki, and K Ishikawa, and T Marunouchi
Mutations that abolish the ability of Ha-Ras to associate with Raf-1.
August 1994, Oncogene,
N Kurata, and H Akiyama, and H Hosoya, and H Aoki, and K Ishikawa, and T Marunouchi
V-ATPase a3 isoform mutations identified in osteopetrosis patients abolish its expression and disrupt osteoclast function.
April 2020, Experimental cell research,
N Kurata, and H Akiyama, and H Hosoya, and H Aoki, and K Ishikawa, and T Marunouchi
Recognition of mos-related proteins with an antiserum to a peptide of the v-mos gene product.
May 1985, The Journal of general virology,
N Kurata, and H Akiyama, and H Hosoya, and H Aoki, and K Ishikawa, and T Marunouchi
[Do not abolish forensic psychiatry but change the legislation].
March 1996, Lakartidningen,
Copied contents to your clipboard!